🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 12 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/10/1999 20,25 25,50 20,06 21,38 +5,56% 26,85% 20.650
05/10/1999 21,38 21,56 18,38 20,25 -0,92% 14,91% 6.883
04/10/1999 21,38 21,75 20,44 20,44 +2,83% 6,14% 4.367
01/10/1999 20,16 20,63 17,25 19,88 -2,75% 16,74% 21.700
30/09/1999 22,50 22,50 18,38 20,44 -8,40% 18,33% 9.967
29/09/1999 22,88 23,06 22,31 22,31 -0,83% 3,28% 4.417
28/09/1999 22,88 23,25 22,50 22,50 -3,23% 3,28% 1.817
27/09/1999 23,91 24,00 23,25 23,25 -0,80% 3,14% 4.717
24/09/1999 24,00 24,00 23,06 23,44 -0,79% 3,91% 2.533
23/09/1999 23,06 24,38 22,50 23,63 -2,33% 8,13% 7.867
22/09/1999 24,56 24,75 23,81 24,19 -0,77% 3,82% 1.983
21/09/1999 24,56 25,13 24,00 24,38 -2,99% 4,58% 2.950
20/09/1999 24,75 25,31 24,38 25,13 +2,29% 3,79% 12.817
17/09/1999 23,91 24,75 23,81 24,56 +3,15% 3,92% 3.817
16/09/1999 23,81 24,38 23,25 23,81 -0,78% 4,72% 17.500
15/09/1999 21,00 24,00 20,81 24,00 +15,32% 15,18% 19.500
14/09/1999 21,47 21,47 20,81 20,81 -2,63% 3,06% 9.633
13/09/1999 23,25 23,44 21,00 21,38 -5,00% 10,48% 11.583
10/09/1999 19,97 35,25 19,97 22,50 +15,38% 76,53% 220.667
09/09/1999 19,50 19,50 19,50 19,50 +0,00% 0,00% 83
08/09/1999 20,91 21,00 19,50 19,50 -3,70% 7,17% 3.217
07/09/1999 19,50 20,25 19,50 20,25 +3,85% 3,85% 450
03/09/1999 19,50 20,63 18,75 19,50 +1,96% 9,62% 3.267
02/09/1999 18,38 19,13 18,38 19,13 +4,08% 4,08% 1.133
01/09/1999 18,38 19,13 18,19 18,38 -3,92% 5,10% 2.133
31/08/1999 18,94 19,50 18,00 19,13 +0,99% 7,92% 6.600
30/08/1999 19,59 19,59 18,38 18,94 +1,00% 6,22% 1.233
27/08/1999 19,88 19,88 18,75 18,75 -7,41% 5,66% 1.650
26/08/1999 20,34 21,00 20,25 20,25 -0,92% 3,69% 4.567
25/08/1999 20,53 20,63 20,25 20,44 -1,80% 1,83% 3.200